# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-23-030690
Filing Date
2023-08-30
Accepted
2023-08-30 17:22:16
Documents
5

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14a.htm | DEFA14A | 16538
2 |  | proxy_001.jpg | GRAPHIC | 514922
3 |  | proxy_002.jpg | GRAPHIC | 257965
4 |  | proxy_003.jpg | GRAPHIC | 1034712
5 |  | proxy_004.jpg | GRAPHIC | 860121
| Complete submission text file | 0001493152-23-030690.txt |  | 3691599

Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

EIN.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41210 | Film No.: 231226166
SIC: 2834 Pharmaceutical Preparations